Staffan Hägg

Staffan Hägg is an Adjunct Professor at the Department of Biomedical and Clinical Sciences, Linköping University. His research focuses on drug safety, adverse drug reactions, and clinical pharmacology. He has contributed to studies on medication risks in elderly populations, psychiatric patients, and acute stroke management. His work emphasizes pharmacovigilance, polypharmacy management, and the development of clinical assessment tools.

Key research areas include drug information utilization by healthcare professionals, pharmacokinetic interactions in surgical patients, and the economic impact of adverse drug events. Recent studies address topics such as gabapentinoid misuse, antipsychotic-associated thrombosis, and the reliability of post-stroke mobility tests.

Publications span over two decades, with notable contributions to understanding fall risks in nursing homes, the clinical effects of switching AMD treatments, and the validation of diagnostic tools for acute stroke patients. His work bridges clinical practice and public health, aiming to improve patient safety and optimize drug therapies.